Literature DB >> 28274927

Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease.

Ryan M Downey1,2, Peizhou Liao3, Erin C Millson4, Arshed A Quyyumi5, Salman Sher5, Jeanie Park6,2.   

Abstract

Chronic kidney disease (CKD) patients have exercise intolerance associated with increased cardiovascular mortality. Previous studies demonstrate that blood pressure (BP) and sympathetic nerve responses to handgrip exercise are exaggerated in CKD. These patients also have decreased nitric oxide (NO) bioavailability and endothelial dysfunction, which could potentially lead to an impaired ability to vasodilate during exercise. We hypothesized that CKD patients have exaggerated BP responses during maximal whole body exercise and that endothelial dysfunction correlates with greater exercise pressor responses in these patients. Brachial artery flow-mediated dilation (FMD) was assessed before maximal treadmill exercise in 56 participants: 38 CKD (56.7 ± 1.2 yr old, 38 men) and 21 controls (52.8 ± 1.8 yr old, 20 men). During maximal treadmill exercise, the slope-of-rise in systolic BP (+10.32 vs. +7.75 mmHg/stage, P < 0.001), mean arterial pressure (+3.50 vs. +2.63 mmHg/stage, P = 0.004), and heart rate (+11.87 vs. +10.69 beats·min-1·stage-1, P = 0.031) was significantly greater in CKD compared with controls. Baseline FMD was significantly lower in CKD (2.76 ± 0.42% vs. 5.84 ± 0.97%, P = 0.008). Lower FMD values were significantly associated with a higher slope-of-rise in systolic BP (+11.05 vs. 8.71 mmHg/stage, P = 0.003) during exercise in CKD, as well as poorer exercise capacity measured as peak oxygen uptake (V̇o2peak; 19.47 ± 1.47 vs. 24.57 ± 1.51 ml·min-1·kg-1, P < 0.001). These findings demonstrate that low FMD in CKD correlates with augmented BP responses during exercise and lower V̇o2peak, suggesting that endothelial dysfunction may contribute to exaggerated exercise pressor responses and poor exercise capacity in CKD patients.

Entities:  

Keywords:  chronic kidney disease; endothelial dysfunction; exercise; exercise pressor reflex; flow-mediated dilation

Mesh:

Substances:

Year:  2017        PMID: 28274927      PMCID: PMC5451552          DOI: 10.1152/ajprenal.00603.2016

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  35 in total

Review 1.  Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective.

Authors:  C Zoccali
Journal:  Kidney Int       Date:  2006-05-24       Impact factor: 10.612

Review 2.  US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Yi Li; Bruce Robinson; Kevin C Abbott; Lawrence Y C Agodoa; John Ayanian; Jennifer Bragg-Gresham; Rajesh Balkrishnan; Joline L T Chen; Elizabeth Cope; Paul W Eggers; Daniel Gillen; Debbie Gipson; Susan M Hailpern; Yoshio N Hall; Kevin He; William Herman; Michael Heung; Richard A Hirth; David Hutton; Steven J Jacobsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Yee Lu; Miklos Z Molnar; Hal Morgenstern; Brahmajee Nallamothu; Danh V Nguyen; Ann M O'Hare; Brett Plattner; Ronald Pisoni; Friedrich K Port; Panduranga Rao; Connie M Rhee; Ankit Sakhuja; Douglas E Schaubel; David T Selewski; Vahakn Shahinian; John J Sim; Peter Song; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Sarah White; Kenneth Woodside; Richard A Hirth
Journal:  Am J Kidney Dis       Date:  2016-03       Impact factor: 8.860

3.  A large blood pressure-raising effect of nitric oxide synthase inhibition in humans.

Authors:  M Sander; B Chavoshan; R G Victor
Journal:  Hypertension       Date:  1999-04       Impact factor: 10.190

4.  Effects of nitric oxide synthase inhibition on vascular conductance during high speed treadmill exercise in rats.

Authors:  T I Musch; R M McAllister; J D Symons; C L Stebbins; T Hirai; K S Hageman; D C Poole
Journal:  Exp Physiol       Date:  2001-11       Impact factor: 2.969

5.  Rostral ventrolateral medulla : A source of sympathetic activation in rats subjected to long-term treatment with L-NAME.

Authors:  C T Bergamaschi; R R Campos; O U Lopes
Journal:  Hypertension       Date:  1999-10       Impact factor: 10.190

6.  Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle.

Authors:  G D Thomas; R G Victor
Journal:  J Physiol       Date:  1998-02-01       Impact factor: 5.182

7.  Exercise pressor reflex in humans with end-stage renal disease.

Authors:  Jeanie Park; Vito M Campese; Holly R Middlekauff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-08-06       Impact factor: 3.619

8.  Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.

Authors:  Jeanie Park; Vito M Campese; Niloofar Nobakht; Holly R Middlekauff
Journal:  J Appl Physiol (1985)       Date:  2008-10-09

9.  Effect of exercise training on aortic tone in chronic renal insufficiency.

Authors:  Stan Shelkovnikov; Scott M Summers; Reza Elahimehr; Gregory Adams; Ralph E Purdy; Nosratola D Vaziri
Journal:  Am J Hypertens       Date:  2008-03-20       Impact factor: 2.689

10.  A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease.

Authors:  Sankar D Navaneethan; Ciaran E Fealy; Amanda C Scelsi; Susana Arrigain; Steven K Malin; John P Kirwan
Journal:  Am J Nephrol       Date:  2015-10-24       Impact factor: 3.754

View more
  14 in total

1.  Metabolic acidosis augments exercise pressor responses in chronic kidney disease.

Authors:  Justin D Sprick; Doree Lynn Morison; Ida T Fonkoue; Yunxiao Li; Dana DaCosta; Derick Rapista; HyunKyu Choi; Jeanie Park
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-29       Impact factor: 3.619

2.  Vascular α1-adrenergic sensitivity is enhanced in chronic kidney disease.

Authors:  Justin D Sprick; Doree L Morison; C Michael Stein; Yunxiao Li; Sachin Paranjape; Ida T Fonkoue; Dana R DaCosta; Jeanie Park
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-07-17       Impact factor: 3.619

3.  Aerobic exercise training improves endothelial function and attenuates blood pressure reactivity during maximal exercise in chronic kidney disease.

Authors:  Justin D Sprick; Kevin Mammino; Jinhee Jeong; Dana R DaCosta; Yingtian Hu; Doree G Morison; Joe R Nocera; Jeanie Park
Journal:  J Appl Physiol (1985)       Date:  2022-02-10

4.  Renin-Angiotensin System Blockade Is Associated with Exercise Capacity, Sympathetic Activity, and Endothelial Function in Patients with Chronic Kidney Disease.

Authors:  Jin Hee Jeong; Justin D Sprick; Dana DaCosta; Arshed A Quyyumi; Jeanie Park
Journal:  Kidney Blood Press Res       Date:  2021-11-10       Impact factor: 2.687

Review 5.  The exercise pressor reflex: An update.

Authors:  André L Teixeira; Lauro C Vianna
Journal:  Clin Auton Res       Date:  2022-06-21       Impact factor: 5.625

Review 6.  Neural control of cardiovascular function in black adults: implications for racial differences in autonomic regulation.

Authors:  Rachel C Drew; Nisha Charkoudian; Jeanie Park
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-12-11       Impact factor: 3.619

Review 7.  The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review.

Authors:  Baris Afsar; Dimitrie Siriopol; Gamze Aslan; Ozgur C Eren; Tuncay Dagel; Ugur Kilic; Asiye Kanbay; Alexandru Burlacu; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2018-01-17       Impact factor: 2.370

Review 8.  Exercise intolerance in kidney diseases: physiological contributors and therapeutic strategies.

Authors:  Danielle L Kirkman; Natalie Bohmke; Salvatore Carbone; Ryan S Garten; Paula Rodriguez-Miguelez; Robert L Franco; Jason M Kidd; Antonio Abbate
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-07

9.  The effect of exercise on blood pressure in chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Stephanie Thompson; Natasha Wiebe; Raj S Padwal; Gabor Gyenes; Samuel A E Headley; Jeyasundar Radhakrishnan; Michelle Graham
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

10.  Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation.

Authors:  Toshihiro Nakano; Kazuhiro Shiizaki; Yutaka Miura; Masahiro Matsui; Keisei Kosaki; Shoya Mori; Kunihiro Yamagata; Seiji Maeda; Takuya Kishi; Naoki Usui; Masahide Yoshida; Tatsushi Onaka; Hiroaki Mizukami; Ruri Kaneda; Kazunori Karasawa; Kosaku Nitta; Hiroshi Kurosu; Makoto Kuro-O
Journal:  Sci Rep       Date:  2019-12-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.